Non-Cell Therapy Achieved 31.4% Adjusted Net Profit Growth Cell Therapy Business Revenue Surged By 70% Revenue of the Group for the year ended December 31, 2022 was approximately US$625.7 million, ...

SOMERSET, N.J.--(BUSINESS WIRE)--Legend Biotech Corporation (NASDAQ: LEGN) (Legend Biotech), a global biotechnology company developing, manufacturing and commercializing novel therapies to treat ...

PITTSBURGH, Feb. 27, 2023 (GLOBE NEWSWIRE) -- Krystal Biotech, Inc. (KRYS), (the “Company”) (NASDAQ: KRYS), a biotechnology company focused on developing and commercializing genetic medicines, today ...

SAN FRANCISCO--(BUSINESS WIRE)--Verge Genomics, a tech-enabled drug discovery company pioneering the use of artificial intelligence (AI) and human data to develop new drugs, announced today that ...

No startup sector was entirely immune from 2022’s market uncertainty — except maybe AI — but some proved more resilient than others. Biotech was one of the most fortunate. The sector recorded 1,054 ...

The ups and downs of the biotech markets have kept the Fierce Biotech team incredibly busy over the past year. Behind the scenes, we have been working hard to bring you in-depth coverage of the ...

Operator: Good morning and welcome to the Trinity Biotech Fourth Quarter 2022 Financial Results Conference Call. All participants will be in listen-only mode. After today’s presentation, there will be ...

When does optimism become criminal? Why can’t biotech find its way back? And what’s going to happen in 2023? We cover all that and more this week on “The Readout LOUD,” STAT’s biotech podcast. We look ...

Verona Pharma plc (NASDAQ:VRNA) is a London-based clinical stage biopharmaceutical company, focused on development and commercialization of therapies for the treatment of respiratory diseases with ...

It has been a challenging year for biotech companies that have gone public within the last two years. However, a quick glance at the Nasdaq Biotechnology Index suggests things are much calmer than ...